{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:54:50Z","timestamp":1794545690881,"version":"4.9.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0006629","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000}}],"reference-count":96,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110110"],"award-info":[{"award-number":["110110"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leverhulme Mandela Rhodes Doctoral Scholarship"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006629","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T13:25:58Z","timestamp":1533561958000},"page":"e0006629","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8398-0689","authenticated-orcid":true,"given":"Jolynne","family":"Mokaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"McNaughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3039-6849","authenticated-orcid":true,"given":"Martin J.","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5639-0528","authenticated-orcid":true,"given":"Apostolos","family":"Beloukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Geretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Goedhals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-4269","authenticated-orcid":true,"given":"Philippa C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Global Hepatitis Programme. Global hepatitis report, 2017. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/<\/ext-link>"},{"key":"ref2","unstructured":"WHO Combating Hepatitis B and C to reach elimination by 2030. Advocacy brief. 2016. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/206453\/1\/WHO_HIV_2016.04_eng.pdf\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/206453\/1\/WHO_HIV_2016.04_eng.pdf<\/ext-link>"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jhep.2016.10.013","article-title":"Battlefield against hepatitis B infection and HCC in Africa","volume":"66","author":"M Lemoine","year":"2017","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1371\/journal.pntd.0005842","article-title":"Hepatitis B virus infection as a neglected tropical disease","volume":"11","author":"GA O\u2019Hara","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4314\/ahs.v15i2.4","article-title":"Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda","volume":"15","author":"P Ocama","year":"2015","journal-title":"Afr Health Sci"},{"key":"ref6","unstructured":"WHO Hepatitis B treatment guidelines. 2015 <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/news\/releases\/2015\/hepatitis-b-guideline\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/news\/releases\/2015\/hepatitis-b-guideline\/en\/<\/ext-link>"},{"key":"ref7","first-page":"1227","article-title":"Hepatitis B Virus Drug Resistance","author":"A Beloukas","year":"2017"},{"issue":"3","key":"ref8","first-page":"1","article-title":"Prevalence, Clinical and Virologic Outcomes of Hepatitis B Virus Co-Infection in HIV-1 Positive Kenyan Women on Antiretroviral Therapy","volume":"8","author":"SL Day","year":"2013","journal-title":"PloS One"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2893.2011.01466.x","article-title":"HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya","volume":"18","author":"HN Kim","year":"2011","journal-title":"J Viral Hepat"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QAI.0b013e3182a60f7d","article-title":"HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes","volume":"64","author":"RL Hamers","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/jac\/dkr388","article-title":"Nucleoside\/nucleotide analogues in the treatment of chronic hepatitis B","volume":"66","author":"J Fung","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3851\/IMP3055","article-title":"HBV genotypes and drug resistance mutations in antiretroviral treatment-na\u00efve and treatment-experienced HBV-HIV co-infected patients","volume":"22","author":"TNA Archampong","year":"2017","journal-title":"Antivir Ther"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/aid.2017.0019","article-title":"Predominance of Hepatitis B Virus Genotype A Among Treated HIV Infected Patients Experiencing High Hepatitis B Virus Drug Resistance in Nairobi, Kenya","volume":"33","author":"SN Mabeya","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"e0152043","DOI":"10.1371\/journal.pone.0152043","article-title":"Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia","volume":"11","author":"G Wandeler","year":"2016","journal-title":"PLoS One"},{"issue":"3\u20134","key":"ref15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000360940","article-title":"Mechanisms of hepatitis B virus resistance development","volume":"57","author":"N Warner","year":"2014","journal-title":"Intervirology"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3748\/wjg.v22.i1.145","article-title":"Overview of hepatitis B virus mutations and their implications in the management of infection","volume":"22","author":"P Caligiuri","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhep.2017.03.027","article-title":"Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy","volume":"67","author":"E Shirvani-Dastgerdi","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02256597","article-title":"Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen","volume":"8","author":"MP Cooreman","year":"2001","journal-title":"J Biomed Sci"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1054\/drup.2001.0190","article-title":"Lamivudine resistance in hepatitis B: mechanisms and clinical implications","volume":"4","author":"KP Fischer","year":"2001","journal-title":"Drug Resist Updat"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/cid\/ciu630","article-title":"Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi","volume":"59","author":"S Aoudjane","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/135965350501000612","article-title":"Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir","volume":"10","author":"J Sheldon","year":"2005","journal-title":"Antivir Ther"},{"issue":"s1","key":"ref22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1478-3231.2010.02399.x","article-title":"Hepatitis B virus resistance to antiviral drugs: where are we going?","volume":"31","author":"F Zoulim","year":"2011","journal-title":"Liver Int"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneph.2012.117","article-title":"Influence of race, ethnicity and socioeconomic status on kidney disease","volume":"8","author":"RE Patzer","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"ref24","first-page":"164","article-title":"Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians","volume":"30","author":"OO Agbaji","year":"2011","journal-title":"West Afr J Med"},{"issue":"suppl_8","key":"ref25","doi-asserted-by":"crossref","first-page":"S792","DOI":"10.1093\/infdis\/jix135","article-title":"Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection","volume":"216","author":"M Buti","year":"2017","journal-title":"J Infect Dis"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcv.2014.03.018","article-title":"Viral evolutionary changes during tenofovir treatment in a chronic hepatitis B patient with sequential nucleos(t)ide therapy","volume":"60","author":"HW Lee","year":"2014","journal-title":"J Clin Virol"},{"key":"ref27","unstructured":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach\u2014Second edition <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/arv\/chapter4.pdf?ua=1\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/arv\/chapter4.pdf?ua=1<\/ext-link>"},{"key":"ref28","unstructured":"World Health Organisation\u2013South Africa HIV Country Profile: 2016 <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/data\/Country_profile_South_Africa.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/data\/Country_profile_South_Africa.pdf<\/ext-link>"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcv.2016.10.017","article-title":"Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa","volume":"85","author":"P Jooste","year":"2016","journal-title":"J Clin Virol"},{"issue":"25","key":"ref30","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1056\/NEJMoa067710","article-title":"The HBV Drug Entecavir\u2014Effects on HIV-1 Replication and Resistance","volume":"356","author":"MA McMahon","year":"2007","journal-title":"N Engl J Med"},{"key":"ref31","first-page":"565","article-title":"The Hepatitis B Virus and Antiviral Drug Resistance: Causes, Patterns and Mechanisms","author":"SA Locarnini","year":"2017"},{"issue":"Suppl 1","key":"ref32","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/jpids\/piu064","article-title":"Prevention of Perinatal Hepatitis B Virus Transmission","volume":"3","author":"NP Nelson","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/infdis\/jiy028","article-title":"Call to Action: Prevention of Mother-to-Child Transmission of Hepatitis B in Africa","volume":"217","author":"P Wilson","year":"2018","journal-title":"J Infect Dis"},{"key":"ref34","unstructured":"WHO UNICEF coverage estimates WHO World Health Organization: Immunization, Vaccines And Biologicals. Vaccine preventable diseases Vaccines monitoring system 2017 Global Summary Reference Time Series: HEPB3. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tswucoveragehepb3.html\" xlink:type=\"simple\">http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tswucoveragehepb3.html<\/ext-link>"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.510300511","article-title":"Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan","volume":"30","author":"H-Y Hsu","year":"1999","journal-title":"Hepatology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"D566","DOI":"10.1093\/nar\/gks1022","article-title":"HBVdb: a knowledge database for Hepatitis B Virus","volume":"41","author":"J Hayer","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1186\/s40064-016-3312-0","article-title":"Bioinformatic curation and alignment of genotyped hepatitis B virus (HBV) sequence data from the GenBank public database","volume":"5","author":"TG Bell","year":"2016","journal-title":"Springerplus"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1756-0500-5-50","article-title":"SSE: a nucleotide and amino acid sequence analysis platform","volume":"5","author":"P Simmonds","year":"2012","journal-title":"BMC Res Notes"},{"key":"ref39","unstructured":"Mokaya J, Hadley M, Matthews P. gene.alignment.tables. Figshare. 2017. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.6084\/m9.figshare.5729229\" xlink:type=\"simple\">10.6084\/m9.figshare.5729229<\/ext-link><\/comment>"},{"key":"ref40","unstructured":"Mokaya J, Hadley M, Matthews P. On-line tool to visualise sites of drug and vaccine escape mutations within the HBV genome. 2018. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/livedataoxford.shinyapps.io\/1510659619-3Xkoe2NKkKJ7Drg\/\" xlink:type=\"simple\">https:\/\/livedataoxford.shinyapps.io\/1510659619-3Xkoe2NKkKJ7Drg\/<\/ext-link>"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jmv.24437","article-title":"Molecular epidemiology and genetic diversity of hepatitis B virus in Ethiopia","volume":"88","author":"GB Hundie","year":"2016","journal-title":"J Med Virol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/JCM.00867-10","article-title":"Hepatitis B Virus (HBV) Infection and Recombination between HBV Genotypes D and E in Asymptomatic Blood Donors from Khartoum, Sudan","volume":"49","author":"S Mahgoub","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcv.2014.11.032","article-title":"Hepatitis B virus infection in post-vaccination South Africa: Occult HBV infection and circulating surface gene variants","volume":"63","author":"E Amponsah-Dacosta","year":"2015","journal-title":"J Clin Virol"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/1756-0500-4-561","article-title":"Emergence of HBV resistance to lamivudine (3TC) in HIV \/ HBV co-infected patients in The Gambia, West Africa","volume":"4","author":"B Stewart","year":"2011","journal-title":"BMC Res Notes"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/jmv.23365","article-title":"Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi","volume":"84","author":"C Galluzzo","year":"2012","journal-title":"J Med Virol"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"e46345","DOI":"10.1371\/journal.pone.0046345","article-title":"Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa","volume":"7","author":"E Makondo","year":"2012","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijid.2014.07.002","article-title":"Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan","volume":"29","author":"M Yousif","year":"2014","journal-title":"Int J Infect Dis"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12879-015-1096-4","article-title":"Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana","volume":"15","author":"M Anderson","year":"2015","journal-title":"BMC Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.meegid.2016.05.035","article-title":"Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study","volume":"43","author":"E Amponsah-Dacosta","year":"2016","journal-title":"Infect Genet Evol"},{"issue":"12","key":"ref50","doi-asserted-by":"crossref","first-page":"e0190149","DOI":"10.1371\/journal.pone.0190149","article-title":"The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia","volume":"12","author":"T Deressa","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"ref51","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/trstmh\/trv077","article-title":"Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral therapy","volume":"109","author":"G Calisti","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3851\/IMP2959","article-title":"Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Cote d\u2019Ivoire","volume":"20","author":"A Boyd","year":"2015","journal-title":"Antivir Ther"},{"key":"ref53","first-page":"2939","article-title":"Outcomes of starting first-line antiretroviral therapy in hepatitis B virus \/ HIV-coinfected patients in Ghana","author":"D Chadwick","year":"2012"},{"issue":"9","key":"ref54","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1128\/JCM.02231-09","article-title":"Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana","volume":"48","author":"AM Geretti","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"e0179025","DOI":"10.1371\/journal.pone.0179025","article-title":"Hepatitis B testing and treatment in HIV patients in The Gambia\u2014Compliance with international guidelines and clinical outcomes","volume":"12","author":"G Ndow","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"e99971","DOI":"10.1371\/journal.pone.0099971","article-title":"Hepatitis B and Delta Virus Are Prevalent but Often Subclinical Co-Infections among HIV Infected Patients in Guinea-Bissau, West Africa: A Cross-Sectional Study","volume":"9","author":"BL H\u00f8nge","year":"2014","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40064-015-0813-1","article-title":"Detection of hepatitis B virus isolates with mutations associated with immune escape mutants among pregnant women in Ibadan, southwestern Nigeria","volume":"4","author":"TOC Faleye","year":"2015","journal-title":"Springerplus"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12981-017-0136-0","article-title":"Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon","volume":"14","author":"G Gachara","year":"2017","journal-title":"AIDS Res Ther"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3851\/IMP1911","article-title":"Original article Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon","volume":"326","author":"C Kouanfack","year":"2012","journal-title":"Antivir Ther"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12985-016-0636-x","article-title":"Serologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon","volume":"13","author":"T Magoro","year":"2016","journal-title":"Virol J"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"e0143869","DOI":"10.1371\/journal.pone.0143869","article-title":"Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV\/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon","volume":"11","author":"B Bivigou-Mboumba","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"e0190592","DOI":"10.1371\/journal.pone.0190592","article-title":"Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence","volume":"13","author":"B Bivigou-Mboumba","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"ref63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0134037","article-title":"Prevalence and characteristics of hepatitis B virus (HBV) coinfection among HIV-Positive women in South Africa and Botswana","volume":"10","author":"PC Matthews","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"ref64","doi-asserted-by":"crossref","first-page":"e0181836","DOI":"10.1371\/journal.pone.0181836","article-title":"HBV infection in untreated HIV-infected adults in Maputo, Mozambique","volume":"12","author":"LM Chambal","year":"2017","journal-title":"PLoS One"},{"issue":"47","key":"ref65","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1016\/j.vaccine.2013.08.028","article-title":"The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa","volume":"31","author":"MI Andersson","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"ref66","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/jmv.24502","article-title":"Complete genome analysis of hepatitis B virus in human immunodeficiency virus infected and uninfected South Africans","volume":"88","author":"MP Gededzha","year":"2016","journal-title":"J Med Virol"},{"issue":"3","key":"ref67","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jmv.24057","article-title":"Mutations associated with occult hepatitis B in HIV-positive South Africans","volume":"87","author":"EA Powell","year":"2015","journal-title":"J Med Virol"},{"issue":"11","key":"ref68","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/jmv.20974","article-title":"Mutations associated with lamivudine-resistance in therapy-naive hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients","volume":"79","author":"SG Selabe","year":"2007","journal-title":"J Med Virol"},{"issue":"6","key":"ref69","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jmv.21479","article-title":"Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes","volume":"81","author":"SG Selabe","year":"2009","journal-title":"J Med Virol"},{"issue":"2","key":"ref70","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmv.24641","article-title":"Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe","volume":"89","author":"I Baudi","year":"2017","journal-title":"J Med Virol"},{"key":"ref71","unstructured":"WHO Clinical guidelines for the management of HIV &amp; AIDS in adults and adolescents. 2010. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/guidelines\/south_africa_art.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/guidelines\/south_africa_art.pdf<\/ext-link>"},{"issue":"2","key":"ref72","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jgh.12831","article-title":"Incidence of natural resistance mutations in na\u00efve chronic hepatitis B patients: A systematic review and meta-analysis","volume":"30","author":"Q Zhang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"ref73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/infdis\/jiv363","article-title":"Combined analysis of the prevalence of drug-resistant Hepatitis B virus in antiviral therapy-experienced patients in Europe (CAPRE)","volume":"213","author":"LE Hermans","year":"2016","journal-title":"J Infect Dis"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jgar.2016.10.012","article-title":"Analysis of the prevalence of drug-resistant hepatitis B virus in patients with antiviral therapy failure in a Chinese tertiary referral liver centre (2010\u20132014)","volume":"8","author":"T Meng","year":"2017","journal-title":"J Antimicr Res"},{"issue":"3","key":"ref75","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3851\/IMP1515","article-title":"Coevolution and HBV drug resistance","volume":"15","author":"Y Khudyakov","year":"2010","journal-title":"Antivir Ther"},{"issue":"5","key":"ref76","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B Virus Resistance to Nucleos(t)ide Analogues","volume":"137","author":"F Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"ref77","unstructured":"WHO Surveillance of transmitted HIV drug resistance. 2013. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/topics\/drugresistance\/surveillance\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/topics\/drugresistance\/surveillance\/en\/<\/ext-link>"},{"key":"ref78","article-title":"New single-day pill for HIV treatment promises more bang for less buck","author":"J Cohen","year":"2017","journal-title":"Science"},{"issue":"4","key":"ref79","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1128\/AAC.02600-12","article-title":"Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside\/nucleotide analogue-naive patients with chronic hepatitis B","volume":"57","author":"B Baran","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref80","article-title":"HBV epidemiology in Taiwan before and after universal vaccination Review Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants","volume":"15","author":"M-H Chang","year":"2010","journal-title":"Antivir Ther"},{"key":"ref81","first-page":"69","article-title":"An Overview of Hepatitis B Virus Surface Antigen Mutant in the Asia Pacific","volume":"16","author":"SA Hudu","year":"2014","journal-title":"Curr. Issues Mol. Biol."},{"issue":"2","key":"ref82","doi-asserted-by":"crossref","first-page":"e0118062","DOI":"10.1371\/journal.pone.0118062","article-title":"Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo Infection","volume":"10","author":"S Hamada-Tsutsumi","year":"2015","journal-title":"PLoS One"},{"key":"ref83","unstructured":"McNaughton A, Lourenco J, Hattingh L, Adland E, Daniels S, Zyl A van, et al. Can we meet global challenges for elimination of Hepatitis B Virus infection by 2030? Vaccine-mediated immunity in a South African cohort and a model of transmission and prevention. bioRxiv. 2017;162594."},{"issue":"11","key":"ref84","doi-asserted-by":"crossref","first-page":"a021550","DOI":"10.1101\/cshperspect.a021550","article-title":"Hepatitis D virus coinfection and superinfection","volume":"4","author":"F Negro","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"ref85","doi-asserted-by":"crossref","first-page":"e992","DOI":"10.1016\/S2214-109X(17)30298-X","article-title":"Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis","volume":"5","author":"AJ Stockdale","year":"2017","journal-title":"Lancet Glob Heal"},{"issue":"16","key":"ref86","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1128\/JVI.00243-16","article-title":"Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation","volume":"90","author":"BD Betz-Stablein","year":"2016","journal-title":"J Virol"},{"issue":"7","key":"ref87","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jmv.21505","article-title":"Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B","volume":"81","author":"F Iacomi","year":"2009","journal-title":"J Med Virol"},{"issue":"10","key":"ref88","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/apt.13795","article-title":"Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa","volume":"44","author":"E Keane","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"ref89","first-page":"1","article-title":"Point of Care Diagnostics for HIV in Resource Limited Settings: An Overview","author":"SL Manoto","year":"2018","journal-title":"medicina"},{"issue":"S7","key":"ref90","doi-asserted-by":"crossref","first-page":"e25007","DOI":"10.1002\/jia2.25007","article-title":"Selecting a viral load threshold for routine monitoring in resource-limited settings: optimizing individual health and population impact","volume":"20","author":"TM Ellman","year":"2017","journal-title":"Journal of the International AIDS Society"},{"issue":"Suppl 1","key":"ref91","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/s12879-017-2776-z","article-title":"Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples\u2014a systematic review and meta-analysis","volume":"17","author":"B Lange","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"12","key":"ref92","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1128\/JCM.05434-11","article-title":"Evaluation of the GeneXpert MTB\/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens","volume":"49","author":"AN Zeka","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"2","key":"ref93","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/JCM.02554-13","article-title":"Rapid detection of hepatitis B virus variants associated with lamivudine and adefovir resistance by multiplex ligation-dependent probe amplification combined with real-time PCR","volume":"52","author":"S Jia","year":"2014","journal-title":"J Clin Microbiol"},{"key":"ref94","unstructured":"Oxford Nanopore Technologies: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/nanoporetech.com\/\" xlink:type=\"simple\">https:\/\/nanoporetech.com\/<\/ext-link>"},{"issue":"s1","key":"ref95","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1872-034X.2007.00098.x","article-title":"Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes","volume":"37","author":"A Kramvis","year":"2007","journal-title":"J Hep Res"},{"key":"ref96","article-title":"A systematic review of Hepatitis B virus (HBV) drug and vaccine escape mutations in Africa\u2014Supplementary data","author":"J Mokaya","year":"2018","journal-title":"Figshare"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0006629","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T16:35:45Z","timestamp":1661704545000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006629"}},"subtitle":[],"editor":[{"given":"Manuel","family":"Schibler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":96,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/258350","asserted-by":"object"}],"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.g001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.g002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.g003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.t001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.t002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.s006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.s007","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pntd.0006629.s008","asserted-by":"subject"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]}}}